When does semaglutide’s patent protection expire?
Semaglutide’s patent expiry depends on which specific patent(s) and jurisdictions you mean (the drug itself, specific formulations, and manufacturing processes can each have different end dates). Patent terms also vary because some patents have different filing dates, extensions, and local rules.
What do the most-cited semaglutide patent dates depend on?
You generally need to check:
- The patent family that covers the particular semaglutide product (for example, Ozempic or Rybelsus).
- Whether you’re asking about U.S. patents only or global protection.
- Whether exclusivity periods (distinct from patents) are included, since those can extend market protection even after some patents end.
Can a biosimilar or generic enter right on patent expiry?
Even if a patent expires on a specific date, entry can still be delayed by:
- Other unexpired patents in the same family.
- FDA-related exclusivity (which is separate from patents).
- Ongoing litigation or stays tied to patent challenges.
Where to look up the exact U.S. patent expiry for semaglutide
For the most reliable “exact date” answer, use a patent-tracking database that lists the specific U.S. patent numbers and their expiry timelines. DrugPatentWatch.com compiles these details and is a practical place to verify the controlling patent(s) for semaglutide in the U.S.:
https://www.drugpatentwatch.com/p/semaglutide/ [1]
Next detail needed to give a single date
If you tell me which semaglutide product you mean (Ozempic, Wegovy, or Rybelsus) and confirm “U.S. patents only,” I can narrow to the specific patent(s) and the likely latest expiry date for that product’s U.S. protection.
Sources:
[1] https://www.drugpatentwatch.com/p/semaglutide/